1Department of Neurology, National Institute of Mental Health & Neurosciences, Bengaluru, Karnataka, India
2Department of Clinical Neurosciences, National Institute of Mental Health & Neurosciences, Bengaluru, Karnataka, India
Copyright © 2023 The Korean Movement Disorder Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of Interest
The authors have no financial conflicts of interest.
Funding Statement
None.
Author Contributions
Conceptualization: Pramod Kumar Pal. Data curation: Bharath Kumar Surisetti, Shweta Prasad. Formal analysis: Bharath Kumar Surisetti, Shweta Prasad. Investigation: Bharath Kumar Surisetti, Shweta Prasad. Methodology: Pramod Kumar Pal. Supervision: Vikram Venkappayya Holla, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal. Validation: Vikram Venkappayya Holla, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal. Visualization: Bharath Kumar Surisetti, Shweta Prasad. Writing—original draft: Bharath Kumar Surisetti, Shweta Prasad. Writing—review & editing: Vikram Venkappayya Holla, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal.
Reference | Phenomenology | No. | Latency | Associated cancer | Treatment | |
---|---|---|---|---|---|---|
Parkinsonism | ||||||
Mehanna et al. [7], 2016 | Akinetic rigid | 3 | Immediate | Glioblastoma | Levodopa resistant | |
7 years | Temporal glioma | Levodopa resistant | ||||
39 years | Posterior fossa tumor | Levodopa resistant | ||||
Bernard et al. [11], 2011 | Akinetic rigid | 1 | 4 weeks | Thalamic and midbrain dysgerminoma | Levodopa responsive | |
Voermans et al. [12], 2006 | Akinetic rigid | 1 | 6 months | Craniopharyngoma | Levodopa resistant | |
Skiming et al. [10], 2003 | Tremor dominant | 1 | 6 months | Levodopa responsive | Levodopa responsive | |
Dystonia | ||||||
Astudillo et al. [15], 2003 | Cervical | 1 | 3 months | Laryngeal carcinoma | NA | |
Landan et al. [14], 1987 | Cervical | 1 | 5 years | Lung carcinoma | NA | |
Salazar et al. [13], 2014 | Oro-mandibular | 2 | 3 weeks | Nasopharyngeal carcinoma | Botulinum toxin injection | |
3 months | Nasopharyngeal carcinoma | Clonazepam | ||||
Soumekh et al. [16], 2005 | Segmental | 1 | 3 months–5 years | Breast carcinoma | Botulinum toxin injection | |
Myoclonus | ||||||
Ahn et al. [20], 2017 | Spinal | 1 | 1 year | Hodgkins lymphoma | Morphine | |
Löscher et al. [19], 2003 | Spinal | 1 | 6 years | Medulloblastoma (cerebellar) | Clonazepam | |
Askenasy et al. [18], 1988 | Spinal | 1 | 3 months | Seminoma | Carbamazepine | |
Cutsforth-Gregory et al. [17], 2017 | Orthostatic | 2 | 4 weeks | Meningioma | No benefit with levetiracetam, clonazepam, levodopa | |
NA | Gliosarcoma | |||||
Tremor | ||||||
Yun et al. [21], 2013* | Palatal | 2 | 3, 6 months | Mid brain-pontine AVM | No specific treatment given | |
Chiou et al. [22], 2006 | Holmes | 1 | 2 weeks | Thalamic AVM | Amantadine and trihexyphenidyl | |
Pomeranz et al. [23], 1990 | Holmes | 1 | 3 weeks | Pineal hamartoma | Surgical resection | |
Ataxia | ||||||
Kumar et al. [25], 2016* | Cerebellar ataxia | 11 | 34 months | Metastatic cancer | No specific treatment given | |
Renard et al. [26], 2010 | Cerebellar ataxia | 1 | 5 months | Metastatic cancer | No specific treatment given |
Reference | No. of patients | Latency | Dental etiology |
---|---|---|---|
Chung et al. [37], 2013 | 1 | 1 year | Dental implant |
Jang et al. [29], 2012 | 2 | NA | Dental extraction |
Chidiac et al. [38], 2011 | 1 | NA | Occlusal adjustment |
Thorburn et al. [30], 2009 | 2 | 3 weeks–6 months | Dental extraction |
Balasubramaniam et al. [36], 2008 | 1 | NA | Oral surgery |
Seeman et al. [39], 2008 | 1 | 8 weeks | Dental filling |
Yoshida [40], 2006 | 2 | 4–8 years | Occlusional splint |
Hamzei et al. [34], 2003 | 1 | Facial -3 hours | Ill-fitting denture |
Laryngeal -3 days | |||
Peñarrocha et al. [41], 2001 | 1 | 2 years | Loss of teeth and occlusal alteration |
Schrag et al. [31]v 1999 | 8 | Hours to 1 year | Dental extraction, dental filling, dentures insertion |
Sankhla et al. [33], 1998 | 21 | 1–16 years | Ill-fitting denture, root canal, gingivectomy, tooth removal |
Thompson et al. [32], 1986 | 1 | NA | Dental extraction |
Sutcher et al. [35], 1971 | 4 | 1 to many years | Ill-fitting denture |
Reference | Procedure | No. | Symptoms and signs | Imaging | Prognosis |
---|---|---|---|---|---|
Tisel et al. [44], 2020 | Asc. AA, AVR, AD, AVR with bypass | 25 | SNGP, Gait impairment, dysarthria, dysphagia, PI, SZ | Midbrain atrophy, SVD, CI in basal ganglia, microbleeds or normal | Progressed in majority |
Lee et al. [45], 2017 | Traumatic AD | 1 | SNGP, dysarthria | Multiple micro bleeds | Progressive |
Kim et al. [48], 2014 | Replacement of thoracic aorta | 1 | SNGP, dysarthria, dysphagia | Multiple micro bleeds | Progressive |
Nandipati et al. [47], 2013 | Asc. AA, AD | 2 | SNGP, dysarthria, dysphagia, blepharospasm, gait disturbance | Callosal and frontal hyperintensities, occipital infarction | One patient died after 2 years. Status of other patient unknown |
Kim et al. [46], 2010 | AD | 1 | SNGP, dysarthria, dysphagia, PI | Normal | Progressive |
Vaughan et al. [49], 2008 | Asc. AA | 1 | SNGP, dysarthria, dysphagia, PI, SZ, cognitive changes | NSWMD | Initial improvement with persistent disability |
Eggers et al. [50], 2008 | AVR, AD | 3 | SNGP, dysarthria, seizures | SVD, hippocampal atrophy, dorsal pontine lesion | Persistent |
Solomon et al. [51], 2008 | AD, AVR | 10 | SNGP, dysarthria, dysphagia, gait disturbances, PI, emotional change | Normal, SVD, diffuse atrophy, posterior thalamic and medial temporal high signal | NA |
Yee et al. [52], 2007 | Asc. AA, AVR, AD, AVR with bypass | 3 | SNGP, dysarthria, dysphagia, gait disturbance, cognitive change | Normal, small infarct in cerebellum, infarct in pons, motor cortex | NA |
Antonio-Santos et al. [53], 2007 | AAA | 1 | SNGP, Gait impairment, dysphagia | CI in parietal lobe | NA |
Kim et al. [54], 2005 | Thoracic AA | 1 | SNGP, dysarthria, PI, dysarthria, blepharospasm, gait abnormality, emotional change | Destruction of bilateral putamen, GP, caudate | NA |
Bernat et al. [55], 2004 | Asc.AA, AVR, AD | 2 | SNGP, Gait impairment, dysphagia, dysarthria | Small infarct in centrum semiovale, normal | One patient stabilized, the other progressed |
Mokri et al. [43], 2004 | Asc.AD, AVR, AD | 7 | SNGP, Gait impairment, dysphagia, PI, dysarthria | Normal, CI in caudate, cerebrum, T2 hyperintensity in temporal lobe | Progressive |
Tomsak et al. [56], 2002 | PDA, AVR | 2 | SNGP, dysarthria, emotional change, blepharospasm | NA | Stabilized |
No., number of patients; AA, aortic aneurysm; Asc., ascending; AVR, aortic valve replacement; AD, aortic dissection; SNGP, supranuclear gaze palsy; PI, postural instability; SZ, seizure; SVD, small vessel disease; CI, chronic infarct; NSWMD, nonspecific white matter disease; AAA, ascending aorta aneurysm; NA, not available; GP, globus pallidus; PDA, patent ductus arteriosus.
Reference | No. | Latency | Previous shunts | Response to shunting | Additional treatment | Drug withdrawal at follow-up |
---|---|---|---|---|---|---|
Prashantha et al. [69], 2008 | 1 | 3 days | 1 | No immediate improvement | Levodopa, THP | Yes |
Zeidler et al. [70], 1998 | 1 | 2 years | 3 | No immediate improvement | Bromocriptine, levodopa | No |
Curran et al. [71], 1994 | 2 | 1 year | 2 | Slow improvement | Levodopa | No |
17 years | 1 | No improvement | Levodopa | Unknown | ||
Gatto et al. [72], 1990 | 1 | 24 years | 1 | Disappeared after shunt | Not given | Not applicable |
Shahar et al. [73], 1988 | 1 | 1 year | Many | No improvement | Unknown | Unknown |
Berger et al. [74], 1985 | 1 | 9 months | 3 | Slow improvement | Benztropine, levodopa | Unknown |
Brazin et al. [75], 1985 | 1 | 2 months | 1 | Slow improvement | Levodopa | Yes |
Reference | Movement disorders | No. | Latency | Spinal disease | Treatment | Improvement |
---|---|---|---|---|---|---|
Pande et al. [79], 2020 | Spinal myoclonus | 1 | 1 month | Lumbar epidural abscess | Clonazepam | Yes |
Sardana et al. [80], 2019 | Propriospinal myoclonus | 1 | 2 years | Dorsal spine surgery | Clonazepam and baclofen | No |
Capelle et al. [9], 2004 | PKD | 6 | 3 months | Cervical disc herniation | Baclofen and tetrazepam | No |
Tremor, myoclonus | 1 day | Lumbar disc herniation | Gabapentin | No | ||
Focal dystonia | 1 week | Lumbar disc herniation | NA | No | ||
Focal hand tremor | 3 months | Cervical disc herniation | Beta blocker, amantadine, levodopa | No | ||
Tremor of both hands | 1 week | Cervical disc herniation | Levodopa, dopamine agonist | No | ||
PKD | 12 months | Multiple disc herniation | NA | No |
Comments on this article
Reference | Phenomenology | No. | Latency | Associated cancer | Treatment | |
---|---|---|---|---|---|---|
Parkinsonism | ||||||
Mehanna et al. [7], 2016 | Akinetic rigid | 3 | Immediate | Glioblastoma | Levodopa resistant | |
7 years | Temporal glioma | Levodopa resistant | ||||
39 years | Posterior fossa tumor | Levodopa resistant | ||||
Bernard et al. [11], 2011 | Akinetic rigid | 1 | 4 weeks | Thalamic and midbrain dysgerminoma | Levodopa responsive | |
Voermans et al. [12], 2006 | Akinetic rigid | 1 | 6 months | Craniopharyngoma | Levodopa resistant | |
Skiming et al. [10], 2003 | Tremor dominant | 1 | 6 months | Levodopa responsive | Levodopa responsive | |
Dystonia | ||||||
Astudillo et al. [15], 2003 | Cervical | 1 | 3 months | Laryngeal carcinoma | NA | |
Landan et al. [14], 1987 | Cervical | 1 | 5 years | Lung carcinoma | NA | |
Salazar et al. [13], 2014 | Oro-mandibular | 2 | 3 weeks | Nasopharyngeal carcinoma | Botulinum toxin injection | |
3 months | Nasopharyngeal carcinoma | Clonazepam | ||||
Soumekh et al. [16], 2005 | Segmental | 1 | 3 months–5 years | Breast carcinoma | Botulinum toxin injection | |
Myoclonus | ||||||
Ahn et al. [20], 2017 | Spinal | 1 | 1 year | Hodgkins lymphoma | Morphine | |
Löscher et al. [19], 2003 | Spinal | 1 | 6 years | Medulloblastoma (cerebellar) | Clonazepam | |
Askenasy et al. [18], 1988 | Spinal | 1 | 3 months | Seminoma | Carbamazepine | |
Cutsforth-Gregory et al. [17], 2017 | Orthostatic | 2 | 4 weeks | Meningioma | No benefit with levetiracetam, clonazepam, levodopa | |
NA | Gliosarcoma | |||||
Tremor | ||||||
Yun et al. [21], 2013 |
Palatal | 2 | 3, 6 months | Mid brain-pontine AVM | No specific treatment given | |
Chiou et al. [22], 2006 | Holmes | 1 | 2 weeks | Thalamic AVM | Amantadine and trihexyphenidyl | |
Pomeranz et al. [23], 1990 | Holmes | 1 | 3 weeks | Pineal hamartoma | Surgical resection | |
Ataxia | ||||||
Kumar et al. [25], 2016 |
Cerebellar ataxia | 11 | 34 months | Metastatic cancer | No specific treatment given | |
Renard et al. [26], 2010 | Cerebellar ataxia | 1 | 5 months | Metastatic cancer | No specific treatment given |
Reference | No. of patients | Latency | Dental etiology |
---|---|---|---|
Chung et al. [37], 2013 | 1 | 1 year | Dental implant |
Jang et al. [29], 2012 | 2 | NA | Dental extraction |
Chidiac et al. [38], 2011 | 1 | NA | Occlusal adjustment |
Thorburn et al. [30], 2009 | 2 | 3 weeks–6 months | Dental extraction |
Balasubramaniam et al. [36], 2008 | 1 | NA | Oral surgery |
Seeman et al. [39], 2008 | 1 | 8 weeks | Dental filling |
Yoshida [40], 2006 | 2 | 4–8 years | Occlusional splint |
Hamzei et al. [34], 2003 | 1 | Facial -3 hours | Ill-fitting denture |
Laryngeal -3 days | |||
Peñarrocha et al. [41], 2001 | 1 | 2 years | Loss of teeth and occlusal alteration |
Schrag et al. [31]v 1999 | 8 | Hours to 1 year | Dental extraction, dental filling, dentures insertion |
Sankhla et al. [33], 1998 | 21 | 1–16 years | Ill-fitting denture, root canal, gingivectomy, tooth removal |
Thompson et al. [32], 1986 | 1 | NA | Dental extraction |
Sutcher et al. [35], 1971 | 4 | 1 to many years | Ill-fitting denture |
Reference | Procedure | No. | Symptoms and signs | Imaging | Prognosis |
---|---|---|---|---|---|
Tisel et al. [44], 2020 | Asc. AA, AVR, AD, AVR with bypass | 25 | SNGP, Gait impairment, dysarthria, dysphagia, PI, SZ | Midbrain atrophy, SVD, CI in basal ganglia, microbleeds or normal | Progressed in majority |
Lee et al. [45], 2017 | Traumatic AD | 1 | SNGP, dysarthria | Multiple micro bleeds | Progressive |
Kim et al. [48], 2014 | Replacement of thoracic aorta | 1 | SNGP, dysarthria, dysphagia | Multiple micro bleeds | Progressive |
Nandipati et al. [47], 2013 | Asc. AA, AD | 2 | SNGP, dysarthria, dysphagia, blepharospasm, gait disturbance | Callosal and frontal hyperintensities, occipital infarction | One patient died after 2 years. Status of other patient unknown |
Kim et al. [46], 2010 | AD | 1 | SNGP, dysarthria, dysphagia, PI | Normal | Progressive |
Vaughan et al. [49], 2008 | Asc. AA | 1 | SNGP, dysarthria, dysphagia, PI, SZ, cognitive changes | NSWMD | Initial improvement with persistent disability |
Eggers et al. [50], 2008 | AVR, AD | 3 | SNGP, dysarthria, seizures | SVD, hippocampal atrophy, dorsal pontine lesion | Persistent |
Solomon et al. [51], 2008 | AD, AVR | 10 | SNGP, dysarthria, dysphagia, gait disturbances, PI, emotional change | Normal, SVD, diffuse atrophy, posterior thalamic and medial temporal high signal | NA |
Yee et al. [52], 2007 | Asc. AA, AVR, AD, AVR with bypass | 3 | SNGP, dysarthria, dysphagia, gait disturbance, cognitive change | Normal, small infarct in cerebellum, infarct in pons, motor cortex | NA |
Antonio-Santos et al. [53], 2007 | AAA | 1 | SNGP, Gait impairment, dysphagia | CI in parietal lobe | NA |
Kim et al. [54], 2005 | Thoracic AA | 1 | SNGP, dysarthria, PI, dysarthria, blepharospasm, gait abnormality, emotional change | Destruction of bilateral putamen, GP, caudate | NA |
Bernat et al. [55], 2004 | Asc.AA, AVR, AD | 2 | SNGP, Gait impairment, dysphagia, dysarthria | Small infarct in centrum semiovale, normal | One patient stabilized, the other progressed |
Mokri et al. [43], 2004 | Asc.AD, AVR, AD | 7 | SNGP, Gait impairment, dysphagia, PI, dysarthria | Normal, CI in caudate, cerebrum, T2 hyperintensity in temporal lobe | Progressive |
Tomsak et al. [56], 2002 | PDA, AVR | 2 | SNGP, dysarthria, emotional change, blepharospasm | NA | Stabilized |
Reference | No. | Latency | Previous shunts | Response to shunting | Additional treatment | Drug withdrawal at follow-up |
---|---|---|---|---|---|---|
Prashantha et al. [69], 2008 | 1 | 3 days | 1 | No immediate improvement | Levodopa, THP | Yes |
Zeidler et al. [70], 1998 | 1 | 2 years | 3 | No immediate improvement | Bromocriptine, levodopa | No |
Curran et al. [71], 1994 | 2 | 1 year | 2 | Slow improvement | Levodopa | No |
17 years | 1 | No improvement | Levodopa | Unknown | ||
Gatto et al. [72], 1990 | 1 | 24 years | 1 | Disappeared after shunt | Not given | Not applicable |
Shahar et al. [73], 1988 | 1 | 1 year | Many | No improvement | Unknown | Unknown |
Berger et al. [74], 1985 | 1 | 9 months | 3 | Slow improvement | Benztropine, levodopa | Unknown |
Brazin et al. [75], 1985 | 1 | 2 months | 1 | Slow improvement | Levodopa | Yes |
Reference | Movement disorders | No. | Latency | Spinal disease | Treatment | Improvement |
---|---|---|---|---|---|---|
Pande et al. [79], 2020 | Spinal myoclonus | 1 | 1 month | Lumbar epidural abscess | Clonazepam | Yes |
Sardana et al. [80], 2019 | Propriospinal myoclonus | 1 | 2 years | Dorsal spine surgery | Clonazepam and baclofen | No |
Capelle et al. [9], 2004 | PKD | 6 | 3 months | Cervical disc herniation | Baclofen and tetrazepam | No |
Tremor, myoclonus | 1 day | Lumbar disc herniation | Gabapentin | No | ||
Focal dystonia | 1 week | Lumbar disc herniation | NA | No | ||
Focal hand tremor | 3 months | Cervical disc herniation | Beta blocker, amantadine, levodopa | No | ||
Tremor of both hands | 1 week | Cervical disc herniation | Levodopa, dopamine agonist | No | ||
PKD | 12 months | Multiple disc herniation | NA | No |
individual patient data not available. No., number of patients; AVM, arterio venous malformation; NA, not available.
No., number of patients; NA, not available.
No., number of patients; AA, aortic aneurysm; Asc., ascending; AVR, aortic valve replacement; AD, aortic dissection; SNGP, supranuclear gaze palsy; PI, postural instability; SZ, seizure; SVD, small vessel disease; CI, chronic infarct; NSWMD, nonspecific white matter disease; AAA, ascending aorta aneurysm; NA, not available; GP, globus pallidus; PDA, patent ductus arteriosus.
No., number of patients; THP, trihexyphenidyl.
No., number of patients; PKD, paroxysmal kinesigenic dyskinesia; NA, not available.